Impact of HSCT on molecular subtypes. (A) OS was depicted according to HSCT and MIPSS70, and (B) the presence of HMR mutation (landmark analysis in supplemental Figure 5). OS was represented in patients with (C) MIPSS70 intermediate and (D) high according to the MTSS score for patients who received transplantation. The number of individuals at risk for the nontransplanted cohort are fractions because of the inclusion of weighting in the analysis.